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Abstract
Although the role of miR-200s in regulating E-cadherin expression and epithelial-mesenchymal
transition is well established, their influence on metastatic colonization remains controversial.
Here, we use clinical and experimental models of breast cancer metastasis to discover a pro-
metastatic role of miR-200s that goes beyond their regulation of E-cadherin and epithelial
phenotype. Overexpression of miR-200s is associated with increased risk of metastasis in breast
cancer and promotes metastatic colonization in mouse models, phenotypes that cannot be
recapitulated by E-cadherin expression alone. Genomic and proteomic analyses revealed global
shifts in gene expression upon miR-200 overexpression toward that of highly metastatic cells.
MiR-200s promote metastatic colonization partly through direct targeting of Sec23a, which
mediates secretion of metastasis suppressive proteins, including Igfbp4 and Tinagl1, as validated
by functional and clinical correlation studies. Overall, these findings suggest a pleiotropic role of
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miR-200s in promoting metastatic colonization by influencing E-cadherin-dependent epithelial
traits and Sec23a-mediated tumor cell secretome.
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Early events of metastatic dissemination are thought to be initiated by epithelial-
mesenchymal transition (EMT) in carcinoma cells, promoting tumor cell migration and
invasion1-3. While implications for EMT in cancer progression are widely recognized, the
potential role of the reverse process, mesenchymal-epithelial transition (MET) is less clear.
Histological analysis has revealed morphological similarities of primary tumors and
metastatic lesions4,and it has been reported that E-cadherin levels are elevated in lymph
node metastases relative to matched primary tumor samples, both suggesting that EMT in
primary tumors may be followed by MET at distant sites5,6. Despite these correlative
clinical findings, rigorous functional studies linking MET with metastatic colonization
ability are scarce.
MicroRNAs (miRNAs) have been recognized as important regulators of normal and
pathological processes in metazoan organisms7-9. Several miRNAs have also been shown
recently to serve as promoters10-15 or suppressors16,17 of metastasis, particularly in the early
step of tumor invasion. However, relatively little is known about the role of miRNAs in the
late step — metastatic colonization of distant organs. The miR-200 family of miRNAs are
important in neurogenesis18, regulation of embryonic and adult stem cells and cancer stem
cells19-22, chemosensitivity and apoptosis23,24. Importantly, miR-200s have recently been
shown to inhibit EMT and promote MET by direct targeting of E-cadherin transcriptional
repressors Zeb1 and Zeb225-28. The fact that the miR-200 family has been shown to enforce
the epithelial phenotype and inhibit EMT and invasion in vitro suggested that these miRNAs
are likely to suppress metastasis. However, functional studies have yielded conflicting
results in different models of metastasis29-31, casting doubt on the potential therapeutic
utility of miR-200s. Furthermore, it remains unclear whether the metastasis-related functions
of the miR-200s are mediated entirely or only partially through the Zeb-E-cadherin axis.
Here, we show that miR-200s promote metastatic colonization of breast cancer not only by
influencing the cell-intrinsic epithelial traits through targeting the Zeb-E-cadherin axis but
also by altering tumor cell-derived secretome through targeting of the Sec23a-mediated
secretion of metastasis suppressive proteins, including Igfbp4 and Tinagl1. These findings
provide novel insights into the molecular functions of miR-200s as well as the role of MET
and tumor secretome in metastasis.
RESULTS
Correlation of miR-200 expression with metastatic colonization
To investigate the clinical significance of miR-200 expression (cluster 1: miR-200b/200a/
429, cluster 2: miR-200c/141, Supplementary Fig. 1a), we performed a retrospective
analysis on a series of breast tumor samples (n = 210, Oxford collection)32. A composite
miR-200 family expression score calculated in each sample as either the median (Fig. 1a, P
= 0.034) or the mean (P = 0.030) expression was significantly associated with poor distant
relapse-fee survival (DRFS)33. In particular, miR-429 and -200a showed the most
significant association with DRFS (Fig. 1a, P = 0.001 for miR-429 and P = 0.050 for
miR-200a). The miR-200 family expression was associated with ER-positive status (P =
0.019, median expression) and correlated with poor DRFS only in the ER-positive tumors (P
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= 0.028, n = 122) but not ER-negative tumors (P = 0.48, n = 77). Furthermore, profiling
miR-200 levels in ten human primary and lung-pleural metastasis samples, including six
matched pairs (Meldola collection),revealed higher expression in metastases, reinforcing the
potential role of miR-200s in metastatic colonization (Fig. 1b). These findings are consistent
with a clinical correlation observed in serous ovarian carcinoma patients34 and an earlier
observation in xenograft studies31.
To further investigate the importance of miR-200s in metastasis, we profiled miR-200
expression levels in three cancer cell line series that model the progression of breast and
bladder cancer. The 4T1 series, including 67NR, 168FARN, 4TO7 and 4T1, are near-
isogenic mouse mammary tumor cell lines. Of these lines, only 4T1 cells are capable of
spontaneously metastasizing and colonizing distant organs following orthotopic
implantation35,36. We found that miR-200s showed greatest expression in the highly
metastatic 4T1 cells (Fig. 1c and Supplementary Fig. 1b), which was consistent with
acquisition of epithelial traits (Fig. 1d and Supplementary Fig. 2a,b) in 4T1 relative to the
weakly metastatic 4TO7 cells37. Similar correlations between elevated expression of
miR-200s with epithelial traits and increased metastatic ability were also made for the
MCF10A human breast cancer38 (Fig. 1e and Supplementary Fig. 1b) and the TSU bladder
carcinoma39 progression series (Supplementary Fig. 2c–e and Supplementary Table 1; see
Supplementary Results). These observations collectively point to the possibility that MET
induced by the miR-200 family may be crucial for successful completion of metastasis,
particularly in the colonization step.
Since E-cadherin is an important mediator of MET, we investigated the clinical importance
of E-cadherin expression in the Oxford cohort. As expected, miR-200 expression was
positively correlated with E-cadherin expression (P < 0.001, Spearman correlation) and
inversely correlated with Vimentin expression (P < 0.001, Spearman correlation). However,
contrary to the clinical associations observed for miR-200s, E-cadherin expression alone did
not have any prognostic power (Fig. 1f), suggesting that the influence of miR-200s on breast
cancer metastasis goes beyond the regulation of E-cadherin and the epithelial phenotype and
likely involves novel genetic targets.
MiR-200 overexpression enhances lung colonization
To directly test the functional role of miR-200s in metastasis, we stably overexpressed
cluster 1 (C1 line), cluster 2 (C2 line) and clusters 1 and 2 simultaneously (C1+C2 line) in
the mesenchymal-like, weakly metastatic 4TO7 cells (Supplementary Fig. 3a). We also
generated E-cadherin (CDH1) overexpressing 4TO7 cells (CDH1 line) to test the importance
of E-cadherin as a major downstream effector of miR-200s in metastasis. Interestingly,
although ectopic expression of cluster 1 enforced expression of miRs-200b/200a/429, cluster
2 elevated expression of all five miRNAs from both clusters (Supplementary Fig. 3a),
possibly due to a double-negative feedback mechanism involving Zeb factors25,40. As
expected, the C1, C2 and C1+C2 lines expressed elevated levels of E-cadherin and lower
levels of Zeb1 (Fig. 2a, b and Supplementary Fig. 3b,c) and adopted an epithelial-like
phenotype (Fig. 2b). Interestingly, EMT inducers such as Snail and Twist, and mesenchymal
markers such as N-cadherin and Vimentin, remained unaffected upon miR-200 expression
(Fig. 2a,b). The CDH1 line also showed elevated expression of E-cadherin but maintained a
mesenchymal morphology (Fig. 2a, b). All engineered lines mentioned possessed similar
growth kinetics in vitro (data not shown) and in vivo (Supplementary Fig. 3d).
Parental 4TO7 cells, when inoculated orthotopically in the mammary fat pad, spontaneously
disseminate to lungs but have a very low efficiency of colonization35,36. C2 (P = 0.035) and
C1+C2 (P = 0.01) lines, both of which overexpress all five members of the miR-200 family,
formed 10–30 fold higher number of lung-derived tumor colonies suggesting that ectopic
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miR-200 expression can enhance lung colonization efficiency (Fig. 2c and Supplementary
Fig. 4a,b; see Supplemental Methods), consistent with an earlier report31. Curiously, the C1
line, which expresses elevated levels of E-cadherin similar to the C2 and C1+C2 lines, was
incapable of efficiently colonizing lungs (Fig. 2c, P = 0.38), implying that 1) E-cadherin is
likely not the only functional downstream effector of miR-200s and 2) gene targeting
mediated by all five members may be necessary to efficiently stimulate metastasis. In
support of this, the CDH1 line also failed to phenocopy the C2 and C1+C2 lines (P = 0.08),
confirming that miR-200-mediated E-cadherin regulation is not sufficient to promote
spontaneous metastatic colonization but rather, other genetic pathways must also be
involved (Fig. 2c and Supplementary Fig. 4a,b).
Since metastasis is a multi-step process, we aimed to elucidate the influence of miR-200s on
early and late steps of metastasis. To determine whether invasion or intravasation was
regulated by miR-200s, whole blood analysis for circulating tumor cells was performed. In
contrast to the results obtained from the lung colony assays, miR-200 expression reduced
tumor cell entry into circulation from primary tumors (Fig. 2d and Supplementary Fig. 5a),
possibly through inhibition of EMT, migration and invasion as observed in vitro
(Supplementary Fig. 5c). Similarly, there was also reduced dissemination of CDH1 cells
from primary tumors (Supplementary Fig. 5b). In aggregate, these data suggested that
although miR-200 expression can hinder entry of tumor cells into circulation, those that do
intravasate may be more capable of colonizing distant organs.
To test this hypothesis, we inoculated cells directly into venous circulation and measured the
incidence of pulmonary metastasis. Tail vein inoculation resulted in enhanced metastasis
burden for all cell lines tested, with C2 (P < 10−7) and C1+C2 (P < 0.01) lines showed the
greatest metastasis potential (Fig. 2e–g). MiR-200 overexpressing lines were only partly
dependent on Cdh1 for colonization since stable knockdown of Cdh1 in C1+C2 lines
modestly but insignificantly reduced colonization potential (Fig. 2h). In summary, results
from both clinical and experimental analyses collectively show that miR-200s can promote
distant colonization of breast cancer cells. However, the fact that E-cadherin overexpression
alone cannot fully recapitulate the metastasis potential of miR-200 overexpressing lines,
suggests that other genes or signaling pathways are also likely to be simultaneously targeted
to enhance colonization efficiency.
miR-200 family induces global changes in gene expression
To identify such novel functional gene and pathway targets of miR-200s, we performed
microarray analysis. Although we observed global changes in gene expression in C2 and
C1+C2 lines, significantly less genetic changes were observed in C1 and CDH1 lines (Fig.
3a). To analyze the extent of the global changes in gene expression observed, we performed
an unbiased hierarchical clustering based on a 1,218 gene-set signature that distinctively
defines the parental 4TO7 and the highly metastatic 4T1 cell lines. Strikingly, we found that
C2 and C1+C2 lines clustered with the highly metastatic 4T1 cells, whereas the C1 and
CDH1 lines remained clustered with the parental 4TO7 cells (Fig. 3a), mirroring their
spontaneous metastasis potentials (Fig. 2c). Rigorous gene set enrichment analyses (GSEA)
were also performed to: 1) confirm the genome-wide shifts in gene expression, 2) reveal that
PicTar-derived miR-200 targets were regulated at a global level, 3) highlight the global
repression of the EMT-like genetic program upon miR-200 expression in 4TO7 cells, 4)
show that Cdh1 overexpression alone causes only a modest expression shift, suggesting that
E-cadherin is unlikely to be the only functional mediator of miR-200s, and 5) reveal that
these genetic changes may influence many cellular functions, including epithelial traits and
protein transport and secretion (Fig. 3b–c, Supplementary Fig. 6, Supplementary Table 2;
see Supplementary Results). Furthermore, there was a significant negative association
between miR-200 family expression and the miR-200 down-regulated gene signature in the
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Oxford cohort of tumor samples (P < 0.001), suggesting that the global changes in gene
expression observed in vitro are likely to be pathologically relevant in breast tumors.
Genomic and proteomic identification of miR-200 targets
Recent studies suggest that in mammalian cells, miRNAs regulate most of their direct
targets at both mRNA and protein levels41. As such, we combined microarray and mass
spectrometry (MS) analysis to identify nine candidate genes down-regulated at both the
RNA and protein level in C1+C2 cells versus control (Fig. 4a,b and Supplementary Table 3;
see Supplementary Results). We confirmed reduced expression of the nine candidate MDA-
MB-231 and TSU-PR1 human breast and bladder cancer cell lines, respectively (Fig. 4d).
Furthermore, miR-200b/200c levels are negatively correlated with mean expression of the
nine candidate genes in the NCI-60 panel of cell lines (Fig. 4e), implying conserved
targeting.
To assess which of these candidate genes are directly targeted by miR-200s, we cloned the
3’-UTRs of eight of the nine candidates for standard luciferase assays. We confirmed direct
targeting of three candidates, including cofilin 2 (Cfl2), low-density lipoprotein receptor-
related protein 1 (Lrp1), and Sec23 homolog A (Sec23a) (Fig. 4f). The 3’-UTRs of Cfl2 and
Lrp1 each contain one functional miR-200 target sequence, while Sec23a contains two
evolutionarily conserved miR-200 target sites that function cooperatively to suppress Sec23a
expression (Fig. 4f and Supplementary Fig. 7).
Sec23a is a miR-200 target that suppresses metastasis
To test which of the three direct targets likely mediates miR-200 function in metastasis, we
stably knocked-down (KD) each of the genes in 4TO7 cells (Supplementary Fig. 8a–c).
Stable KD did not influence morphology (Supplementary Fig. 8a), cell proliferation or E-
cadherin expression (data not shown). Of the three genes, Sec23a KD reduced transwell
migration (Fig. 5a) and enhanced pulmonary colonization (Fig. 5b,c), phenocopying
miR-200 overexpression (Supplementary Fig. 5c; Fig. 2e,f). In support of the functional
data, endogenous Sec23a levels are less abundant in highly metastatic 4T1 and MCFCA1a
lines relative to the weakly metastatic 4TO7 and MCFCA1h lines and is reduced in 4TO7
line upon miR-200 overexpression (Supplementary Fig. 8d–e). Furthermore, SEC23A levels
are significantly lower in clinical metastases relative to primary tumors (Fig. 5d–e),
consistent with its role as a suppressor of metastatic colonization.
Neither knockdown in 4TO7 cells nor overexpression of Sec23a in 4TO7-C1C2 cells
significantly influenced spontaneous metastasis (Supplementary Fig. 8f–h). Since Sec23a
inhibits migration but increases colonization, it is possible that these two effects may
balance out each other. Indeed, evaluation of SEC23A expression as a primary tumor
prognostic marker in a large public clinical database of breast cancer42 failed to show
significant associations. Overall, both clinical data analysis and experimental animal models
suggest that Sec23a plays an important role in suppressing metastasis specifically at the step
of colonization. However, it should be noted that although Sec23a KD can enhance
metastatic colonization, overexpression of Sec23a alone is not sufficient to significantly
suppress metastasis (Supplementary Fig. 8i,j).
miR-200 overexpression suppresses Sec23a-mediated secretion
Sec23a is an essential component of COPII vesicles and is involved in anterograde transport
of proteins from the ER to Golgi apparatus. Although several recent studies have shown that
Sec23a is indispensible for the secretion of ECM components such as collagens and
cartilage oligomeric matrix protein (Comp), and in craniofacial and chondrocyte
development43-45, little else is known of other classes of proteins influenced by Sec23a-
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mediated secretion and the potential role they may play in metastasis. To this end, we
performed mass spectrometry analysis on conditioned media (CM) from two Sec23a KD
lines. There was a global reduction in protein secretion (Supplementary Fig. 9a), including
those involved in wounding (P = 6.4e−6), cell adhesion (P = 1.6e−5), extracellular structure
organization (P = 3.8e−3), inflammatory and immune responses (P = 1.0e−4 and P = 4.0e−4
respectively) (Supplementary Table 4) as defined by the Database for Annotation,
Visualization and Integrated Discovery (DAVID ) Bioinformatics Resources46. Reduced
secretion led to intracellular accumulation of proteins such as Comp44 (Supplementary Fig.
9b) which in turn resulted in modest ER distension as assessed by electron microscopy (EM)
analysis (Supplementary Fig. 9c). There were strong correlations of Sec23-dependent
secreted proteins between the two KD lines (Fig. 6a, R = 0.9, P < 0.0001) and between
Sec23a KD#2 and the C1+C2 line (Fig. 6a, R = 0.43, P < 0.001). Similar to the Sec23a KD
line, C1+C2 line also showed modest ER distension by EM analysis, suggesting functional
disruption of protein transport (Supplementary Fig. 9c). Taken together, these data suggest
that expression of Sec23a and the secretory pathway are inhibited by miR-200s.
Igfbp4 and Tinagl1 are Sec23a-dependent metastasis suppressors
To evaluate the clinical importance of the secretome in cancer progression in human breast
cancer patients, we analyzed the expression of 35 of 38 genes that were significantly
reduced in secretion in both Sec23a KD lines (secretome gene signature) (Fig. 6a), in a large
public microarray database42. Analysis revealed that low expression is significantly
correlated with reduced RFS (Fig. 6b, P = 0.0236), reinforcing the role of these genes as
metastasis suppressors. In contrast, average expression of eight of nine candidate miR-200
target genes identified through combined genomic and proteomic analysis (Fig. 4a,b)
showed correlation with good RFS but failed to reach significance (P = 0.13, data not
shown), highlighting the prominent influence of the Sec23a-mediated secretome in
metastasis-free survival.
To uncover the central mediators of the secretome that possessed metastasis-related
functions, we functionally tested three of six genes — Axl receptor tyrosine kinase (Axl),
tubulointerstitial nephritis antigen-like 1 (Tinagl1) and insulin-like growth factor binding
protein 4 (Igfbp4) — from the secretome signature that were significantly associated with
RFS (Supplementary Fig. 9d). Stable knockdown of Tinagl1 and Igfbp4 in 4TO7 cells
(Supplementary Fig. 9e) enhanced colonization after intravenous injection (Fig. 6c,d),
phenocopying miR-200 overexpression and Sec23a KD. Importantly, both TINAGL1 and
IGFBP4 were also significantly associated with better distant metastasis-free survival in an
independent EMC286 clinical dataset47 (Fig. 6e), again supporting their role in reducing
metastasis. Furthermore, IGFBP4 expression showed a significant lung-tropic association
(Supplementary Fig. 9f) with metastases in the MSK82 clinical dataset48. In aggregate, our
data implicates a significant role for the secretome as an important downstream mediator of
miR-200s in metastasis, and uncovers Tinagl1 and Igfbp4 as secreted suppressors of lung
metastasis with potential therapeutic applications.
Discussion
In this study, we show that miR-200s promote metastastic colonization through mechanisms
that go beyond cell-intrinsic regulation of epithelial traits through the Zeb1/2-E-cadherin
axis (Fig. 6f). MiR-200s also influence tumor cell secretome by direct targeting of Sec23a-
mediated transport pathway, which affects cell-extrinsic tumor-stromal interactions. We
further identified Tinagl1 and Igfbp4 as important Sec23a-mediated secretory proteins that
significantly reduce metastatic colonization. Our findings support the dynamic roles of EMT
and MET during different stages of metastasis — while EMT and low levels of miR-200s
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promote invasion and intravasation, MET and high miR-200 expression is required for
efficient colonization of secondary organs.
The biphasic role of miR-200s in metastasis
Here, we present the first large scale breast cancer clinical study showing a significant
clinical association of miR-200 family expression with poor DRFS, particularly in ER-
positive breast cancers. Furthermore, miR-200 expression was increased in lung metastases
compared to primary tumors. In support of the clinical associations, a survey across several
different isogenic series of cancer cell lines revealed a strong correlation between miR-200
expression and metastatic ability, which was further supported by functional analysis in
vivo.
Several recent studies in animal metastasis models have reported conflicting roles of
miR-200s in metastatic progression29-31. These contradictory findings may in part due to the
different models applied in these studies, where miR-200s may promote metastasis of breast
cancer cells31 and hinder metastasis of lung adenocarcinoma29 and pancreatic
neuroendocrine cells30. However, it is more likely that the final outcome of miR-200s in
metastasis progression of various cancers depends on several variables such as the
difference in the rate-limiting step of the metastatic cascade and the importance of MET in
colonization in different models. In the model system we applied, the 4TO7 tumor cells are
inherently highly migratory and invasive in vitro and in vivo, and although ectopic miR-200
expression reduces dissemination, it has a net effect of enhancing the rate-limiting
colonization step. In contrast, this outcome is less likely in model systems where earlier
steps of metastasis, such as early dissemination through acquisition of EMT-like properties,
is the rate-limiting process, as may be the case for the model systems showing metastasis-
suppressor functions of miR-200s29,30 (see Supplementary Discussion for further discussion
on the biphasic role of miR-200s).
miR-200s influence cell-intrinsic and -extrinsic pathways
In our present study, both clinical and functional data revealed that E-cadherin alone is
insufficient to recapitulate all miR-200 phenotypes, suggesting that miR-200s likely
influence other genes or pathways during metastasis. We used integrated genomic and
proteomic analysis to obtain a comprehensive understanding of the impact of miR-200s on
gene expression in cancer cells. MiR-200 overexpression led to sweeping changes in gene
expression toward that of the most metastatic cells. In addition to genes and pathways
controlling epithelial characteristics, additional cellular processes such as protein transport
and secretion were also implicated in miR-200-dependent regulation of metastatic ability.
Importantly, we showed that the expression of Sec23a is directly suppressed by miR-200s
through two evolutionarily conserved target sequences in its 3’-UTR (see Supplementary
Discussion for summary of evidence supporting Sec23a as a functional target miR-200s).
Thus, in addition to the well established function of miR-200s in regulating intrinsic cellular
properties through Zeb1/2 and E-cadherin, miR-200s may also possess the potential to
influence the microenvironment by directed targeting of Sec23a-dependent secretome.
Through regulation of this pathway, miR-200s may extend their reach to manipulate a
neighboring population of tumor and stromal cells, influencing their collective behavior
during metastasis. The ability of miRNAs to influence cell-intrinsic and –extrinsic properties
of tumor cells has also recently been uncovered for the miR-17/20 cluster49-51. The miR-200
family and the miR-17/20 cluster may represent a growing number of miRNAs with the
ability to influence both intracellular regulatory machineries and intercellular
communication of tumor and stromal cells (see Supplementary Discussion for further
comments on the role of secreted components in metastasis).
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In summary, our study combined clinical and experimental studies to establish a biphasic
role miR-200s in metastasis. We showed that miR-200s promote metastatic colonization by
enhancing cell-intrinsic epithelial traits via the Zeb-E-cadherin axis and by inhibiting
Sec23a-dependent regulation of tumor secretome. The fact that miR-200 targeting of Sec23a
appears to have dichotomous roles in metastasis, hindering early steps of migration and
invasion while promoting late step of metastatic colonization, may explain the contradictory
roles of miR-200s in various models of metastasis. Although miR-200s and the Sec23a
pathway may represent new therapeutic opportunities for metastatic cancer, their
dichotomous functions warrant careful assessment of potential therapeutic benefits and
adverse side effects when treatments are applied at different stages of the disease.
METHODS
Tumor xenografts
All procedures involving mice, such as housing and care, and all experimental protocols
were approved by Institutional Animal Care and Use Committee (IACUC) of Princeton
University. Cells were harvested from subconfluent cell culture plates, washed with PBS
twice, and re-suspended at the appropriate concentration in PBS. 2×105 cells in 0.1 ml PBS
were injected on day 0 into the lateral tail vein of 4-week-old, female BALB/c mice (NCI)
using 26 G needles to generate pulmonary metastasis. For orthotopic primary tumor
formation, female BALB/c mice at 6 weeks old were anaesthetized and a small incision was
made to reveal the mammary gland. 106 cells resuspended in 10 μl PBS were injected
directly into the mammary fat pad. The primary tumor growth was monitored weekly by
measurement of the tumor size.
Statistical analysis
Results were reported as mean ± s.e.m. (standard error of the mean). Two-sided independent
Student’s t-test without equal variance assumption or the Wilcoxon signed-rank test was
performed to analyze gene and miRNA expression levels, differences in number of tumor
colonies and nodules, end-points of in vitro luciferase assays and histology data. For clinical
associations, Spearman rank correlation coefficients were used for studying the association
between continuous variables. Tests of hypotheses on the location parameter (median) were
performed using Mann-Whitney and Kruskall-Wallis. The log-rank test was used to test for
differences in survival in univariate analysis. Expression values were introduced into
survival analysis as continuous variables using a non-parametric approach in which samples
were ranked by expression values, and ranks were normalized between 0 and 1. Statistical
analyses were performed using R (www.r-project.org). DRFS and RFS were calculated as
described by the STEEP criteria33. A standard chi-square goodness of fit test was used to
determine significance of overlap in number of enriched GO categories between samples.
Additional experimental procedures are listed in the Supplementary Methods.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
MiR-200s are associated with poor prognosis in breast cancer. (a) Kaplan-Meier curves
showing the distant relapse-free survival of 210 patients with high or low expression of the
entire miR-200 family (top panel), miR-429 (middle panel) and miR-200a (bottom panel) in
breast tumors. P values were computed by a likelihood ratio test. (b) Box plots showing
miR-200 expression levels in ten human primary and metastasis samples as assessed by
qRT-PCR analysis. Data is normalized to U6 and P values were computed by Student’s t-
test. (c) Heat map showing miRNA expression levels in 4T1 series. 168: 168FARN. (d)
Phase contrast images (left panel) and immunofluorescence (IF) images of 4TO7 and 4T1
cells stained for E-cadherin (right panel). (e) Phase contrast images (left panel) and IF
images for E-cadherin (right panel) of MCFCA1h and MCFCA1a cells. Inserts highlight the
membrane localization of E-cadherin. (f) Kaplan-Meier curves showing the distant-relapse
free survival of 210 patients with high or low CDH1 expression. P values were computed by
a likelihood ratio test.
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Figure 2.
Ectopic miR-200 expression enhances spontaneous metastasis and colonization of distant
organs. (a) Western blot showing expression of indicated proteins in various genetically
modified 4TO7 cell lines. (b) Phase contrast and IF images of cell lines stained for E-
cadherin and N-cadherin. Yellow outline emphasizes cell morphology. (c) Various cell lines
were used to generate orthotopic mammary gland tumors. After one month, lungs were
excised, dissociated and plated in selective media for colony formation. Average numbers of
colonies were listed below representative plate images. Data represent mean ± s.e.m. from a
single representative experiment out of three independent experiments. (n = 9–10). (d) Dot
plot showing relative expression of puromycin resistance gene, an indicator of circulating
tumor cells, by qRT-PCR analysis of genomic DNA from whole blood samples. Red lines
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represent median values. P = 0.02 (Student’s t-test). (e) Representative gross lung and H&E
stained lung sections from animals intravenously injected with various 4TO7 cell lines. Red
arrowheads and dotted lines highlight metastatic nodules. (f) Immunohistochemical staining
for E-cadherin of lung nodules established from indicated cells. (g) Bar graph showing fold
increase in number of pulmonary metastasis nodules for each group. Data represent mean
fold increase ± s.e.m. from a single representative experiment out of three independent
experiments. (n = 9–10). (h) Left: RT-PCR showing expression of Cdh1 in C1C2 cells with
or without stable Cdh1knockdown. Right: Bar graph showing number of pulmonary lesions
following intravenous inoculation of tumor cells. * P < 0.05, ** P < 0.01 (Student’s t-test).
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Figure 3.
Ectopic miR-200 expression promotes global changes in gene expression. (a) Unsupervised
clustering highlighting genome-wide changes in gene expression upon miR-200 expression
in 4TO7 cells. Experiment was performed twice in duplicates. (b) GSEA showing influence
of miR-200 overexpression on the overall gene expression profile of 4TO7 cells. Gene sets
used are the top 100 (left panel) and bottom 100 (right panel) differentially expressed genes
in the test (C1, C2, C1+C2 and CDH1) vs control lines. Gene list used include all mouse
genes ranked by their differential expression between 4T1 and 4TO7. Enrichment of top and
bottom 100 genes from 4T1 vs. 4TO7 ranked list is shown as an example of maximum
possible enrichment. ES: enrichment score. NES: normalized enrichment score. Red and
blue arrows denote the relative number of core genes for each analysis. (c) Venn diagram
showing significant overlap of core genes from top 100 gene sets for C1 (red circle), C2
(blue circle) and C1+C2 (green circle) lines from (b). Common core genes between C1, C2
and C1+C2 lines are presented. Cdh1 is highlighted in red font to emphasize the positive
influence of miR-200s on E-cadherin expression.
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Figure 4.
Identification of putative miR-200 targets using mass spectrometry. (a) Scatter plot shows
the comparison between protein abundance and mRNA abundance for 1562 proteins in
C1+C2 versus control cells. Red dots represent genes with miR-200 target sites. (b)
Comparison between protein abundance and mRNA abundance for genes containing
miR-200 target sites (n =130). Genes highlighted by red dots represent those that are
significantly reduced in expression at both mRNA and protein level (n = 9). Dots confined
within orange dashed circle represent genes harboring miR-200 target sites showing little or
no change in gene expression. (c) qRT-PCR validation of reduced expression of the nine
candidate genes highlighted by red dots in panel (b) in C1+C2 line compared to the control.
Data represent mean ± s.e.m. * P < 0.05 (Student’s t-test). (d) Heat map showing expression
of nine candidate genes in MDA-MB-231 (left) and TSU-PR1 (right) cells upon transient
transfection of miR-200s. ZEB1 and ZEB2 were included as positive controls. (e) Heat map
showing negative correlation between average expression of nine-candidate gene signature
and miRs-200b and -200c in NCI-60 panel of cell lines. (f) Direct targeting of eight of nine
candidate genes was tested by luciferase assays in HeLa cells. Data represents percent
change in normalized luciferase activity after co-transfection of miR-200s relative to the
negative control pre-miR ± s.e.m. * P < 0.05, ** P < 0.01 (Student’s t-test).
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Figure 5.
Sec23a knockdown phenocopies miR-200s in inhibiting migration and promoting metastatic
colonization. (a) Transwell migration assays were performed in triplicate and is presented as
the mean migration of experimental lines as a ratio relative to parental 4TO7 cells ± s.e.m. *
P < 0.05 (Student’s t-test). (b) Bar graph showing fold change in number of pulmonary
nodules relative to 4TO7 parental line. Data presented as mean ± s.e.m. * P < 0.05
(Student’s t-test). (c) Representative gross lung images and H&E stained lung sections
(lower panel) from mice intravenously injected with various cell lines as indicated. Red
arrows were used to highlight metastatic nodules, except in Sec23a-KD samples which
contained large numbers of nodules. (d) Box plot showing relative expression of SEC23A in
ten human primary tumors versus ten metastases. GAPDH was used to normalize
expression. P value computed by Student’s t-test. (e) Bar graph showing relative expression
of SEC23A in matched primary and metastasis samples collected from six individuals.
GAPDH was used to normalize expression. * P < 0.05 (Student’s t-test).
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Figure 6.
Sec23a knockdown disrupts secretion of proteins that are correlated with suppression of
clinical metastasis. (a) Scatter plot showing correlation of secretome profiles between two
different Sec23a KD lines and between Sec23a KD and C1+C2 lines. Proteins in common
between different lines were used to generate the plots. Orange dots represent proteins
reduced in abundance in both conditions; green dots represent proteins increased in
abundance in both conditions whereas gray dots represent those proteins that show
discordant expression patterns. (b) Kaplan-Meier curves showing relapse-free survival of
patients with high and low median expression level of 35 genes reduced in secretion in
Sec23a KD lines. (c) Bar graph showing fold increase in number of pulmonary metastases in
4TO7-derived lines stably knocking down Axl, Tinagl1 or Igfbp4 relative to vector control.
(d) Representative gross lung images from animals injected via lateral tail vein with various
knockdown lines from (c) along with vector control. ** P < 0.01 (Student’s t-test). (e)
Kaplan-Meier plots of distant metastasis-free survival of patients in the EMC286 dataset
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stratified by expression of TINAGL1 (top) or IGFBP4 (bottom). P values were computed by
log-rank test. (f) Schematic model of miR-200 function during metastasis. MiR-200s
simultaneously target several genes including Zeb1, ZEB2 and Sec23a to inhibit local
invasion but promote metastatic colonization. Targeting of Zeb1/2 influences cell-intrinsic
epithelial traits whereas targeting of Sec23a modulates tumor-derived secretion of factors
such as Igfbp4 and Tinagl1, which influence metastatic colonization by altering tumor-
stromal interactions.
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